aod9604 efficacy fat loss clinical trials AOD-9604 vs Semaglutide for longevity

B12 Injections in Anchorage AK | Vitamin Shots

Absence of Systemic Endocrine Disruption# Across six Phase I/II trials running ~900 subjects, AOD-9604 produced no meaningful changes in IGF-1, fasting glucose, HbA1c, insulin sensitivity, or lipid parameters at any tested dose

longevity

Preservatives:Yes (Water Based + Preservatives)

Examples: manual muscle testing grades by major muscle groups transfer ability (sit-to-stand, bed-to-chair) gait observations and balance findings functional test results (timed sit-to-stand, walking tolerance, assistive device use) Step 3: Prove functional impact Link weakness to daily life: bathing, dressing, toileting meal prep, household mobility fall risk and safety concerns work limitations when relevant Step 4: Exclude focal and neurologic patterns Document why this is generalized rather than focal: no unilateral deficit pattern no dermatomal-only weakness pattern